AltraTech

Altratech is an Irish biotechnology company specializing in the development of next-generation molecular diagnostic technology. The company has created a platform for multianalyte point-of-care diagnostics that combines nucleic acid (DNA/RNA) and serological (antibody/antigen) testing in a single, sample-to-result workflow. Their technology utilizes proprietary PNA probes for high specificity and a digital CMOS sensor chip for detection, quantification, and digital readout. The system is being miniaturized into a low-cost, single-use disposable cartridge designed for use with a solid-state, portable instrument, aiming for rapid diagnosis in under one hour without the need for enzymatic steps like PCR.

This innovation is designed to facilitate rapid triage and patient treatment in decentralized, non-laboratory settings, including home health monitoring, remote clinical trials, and veterinary applications. By providing a portable and commercially viable diagnostic solution, Altratech aims to support early disease intervention and improve global accessibility to testing. The company, which is supported by a multidisciplinary team of scientists and engineers, has built an extensive portfolio of proprietary patents and has received funding and research support from various international organizations, including the European Innovation Council, the Bill & Melinda Gates Foundation, and the U.S. BARDA DRIVe program.